RxDoctor Payments Data

Robert Blackwood, PA

Physician Assistant · Clinton, NCNPI 1619137270

Payments from drug & device makers

$20,616in general payments, 2019–2025

Across 153 payments — averaging $134.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$16K
  • Medtronic$2K
  • Boston Scientific$2K
  • Johnson & Johnson$265
  • Baxter Healthcare$201
  • Esperion Therapeutics, Inc.$140
  • plus $991 from 14 others

What the payments were for

  • Speaking & faculty fees$14,25069%
  • Travel & lodging$1,0705%
  • Food & beverage$5,29626%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$20,616 in reported general payments places this provider in the 95th percentile of 7,441 physician assistant providers in North Carolina.

See all physician assistant providers in North Carolina

Medicare billing

Part B allowed, 2024
$51,255
Medicare patients
233
Services billed
709

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban304$215,287
EntrestoSacubitril/Valsartan166$129,493
XareltoRivaroxaban47$35,397
JardianceEmpagliflozin28$22,661
FarxigaDapagliflozin Propanediol20$11,699
Repatha SureclickEvolocumab16$8,546
Dofetilide49$7,379
Flecainide Acetate106$3,595
Ranolazine ErRanolazine55$3,564
Metoprolol Succinate355$3,142
Amiodarone Hcl149$2,205
Diltiazem 24hr Er (Cd)Diltiazem Hcl32$1,316
Midodrine Hcl34$1,123
SotalolSotalol Hcl53$823
Metoprolol Tartrate114$814

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$29$215,287304 claims
NovartisEntresto$101$129,493166 claims
Johnson & JohnsonXarelto$265$35,39747 claims
Boehringer IngelheimJardiance$65$22,66128 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 7,441 physician assistant providers in North Carolina.

Other physician assistant in Clinton

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →